Page 1 of 1

FDA Regulatory Risk Opinion — Engagement Intake

This intake initiates a confidential, transaction-specific FDA regulatory risk opinion prepared for sponsor-side diligence and investment decision-making.

Requester Qualification

What is your role in this transaction?

Private Equity / Growth Equity

Venture Capital

Corporate Development / M&A

Legal Counsel / Advisor

Investment Committee Support

Other

Firm / Organization Name

Work Email Address

Transaction Context

Transaction Type

Acquisition

Minority Investment

Majority Investment

Platform / Add-On

Strategic Partnership

Other

Target Company Name

Estimated Transaction Size

Under $50M

$50M–$150M

$150M–$500M

$500M+

Not yet finalized

When is this regulatory input required?

Within 7 days

1–2 weeks

2–4 weeks

Exploratory / Pre-LOI

Regulatory Surface Area

Which FDA-regulated areas are relevant to this transaction? (Select all that apply)

Drug products (CDER)

Biologics (CBER)

Medical devices

Combination products

Cell or gene therapy

Contract manufacturing (CMO / CDMO)

Other

Current Regulatory Status of the Target

Commercial manufacturing

Clinical-stage

Preclinical

Mixed / multiple programs

Briefly describe any known FDA inspections, Form 483s, warning letters, recalls, or significant compliance events.

Supporting Materials

Upload any available materials relevant to regulatory risk (optional but recommended) - Examples include quality manuals, SOP indices, inspection histories, audit summaries, or existing diligence materials.

Size limit: 10 MB

Acknowledgements

Scope of Engagement

I acknowledge this engagement is limited to a written, decision-support FDA regulatory risk opinion and does not include compliance implementation, remediation, or certification services.

Confidentiality

I confirm that all submitted information and materials may be used solely for purposes of this confidential regulatory risk assessment.

Engagement Acceptance

I understand that engagements are accepted selectively and are subject to scope confirmation prior to initiation.